MedTrace Logo

Study of Two Marketed Ocular Anti-Allergy Medications in Subjects With Allergic Conjunctivitis

NCT00534794 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2015-05-13

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to compare the effects of two marked ocular anti-allergy medications in cat sensitive subjects with allergic conjunctivitis.

Conditions

  • Allergic Conjunctivitis

Interventions

DRUG

Elestat

Elestat BID for 2 days

DRUG

Pataday

Pataday QD for 2 days

Sponsors & Collaborators

Principal Investigators

  • Michael Raizman, MD · Ophthalmic Consultants of Boston

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-10-31
Primary Completion
2008-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00534794 on ClinicalTrials.gov